Hoffecker G, Varughese LA, Bleznuck J, Landgraf J, Wollack C, Chen J, Ritchie MD, Nathanson KL, Tuteja S
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers
- PMID: 37303270
- DOI: 10.1002/cpt.2957
- Article on PubMed
Establishing a patient-centered, multidisciplinary pharmacogenomics clinic in an academic health system: Successes, challenges, and future direction
Glenda Hoffecker Pharm.D, Mari Cayabyab Pharm.D, Lisa A. Varughese Pharm.D., M.S., Stephanie Byers Asher M.S., Archna Bajaj M.D., Sony Tuteja Pharm.D., M.S.
- DOI: 10.1002/jac5.1868
NIH funds new Genomics and Public Service Fellowship Program
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has awarded the American Society of Human Genetics (ASHG) a five-year, $7.1 million contract to support a new Genomics and Public Service Fellowship Program, which will provide early-stage professionals with experience in a range of genomics careers.
“Careers in genomics extend well beyond the laboratory now. There is an entire rainbow of opportunities to advance genomics in research, medicine and society,” said NHGRI Director Eric Green, M.D., Ph.D. “Future advances in genomics will need the next generation of minds working in the education, communications, policy and scientific program areas. This new ASHG-NHGRI fellowship program will provide novel training opportunities to foster such experts.”
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
- PMID: 36739136
- DOI: 10.1016/S0140-6736(22)01841-4
- Article on PubMed
Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
- PMID: 37058144
- DOI: 10.1016/j.gim.2023.100812
- Article on PubMed
Integrated multi-omics for rapid rare disease diagnosis on a national scale
- PMID: 37291213
- DOI: 10.1038/s41591-023-02401-9
- Article on PubMed
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Chad A Bousman, James M Stevenson, Laura B Ramsey, Katrin Sangkuhl, J Kevin Hicks, Jeffrey R Strawn, Ajeet B Singh, Gualberto Ruaño, Daniel J Mueller, Evangelia Eirini Tsermpini, Jacob T Brown, Gillian C Bell, J Steven Leeder, Andrea Gaedigk, Stuart A Scott, Teri E Klein, Kelly E Caudle, Jeffrey R Bishop
- PMID: 37032427
- DOI: 10.1002/cpt.2903
- Article on PubMed
Scientists release a new human “pangenome” reference

Researchers have released a new high-quality collection of reference human genome sequences that captures substantially more diversity from different human populations than what was previously available. The work was led by the international Human Pangenome Reference Consortium, a group funded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health.
The new “pangenome” reference includes genome sequences of 47 people, with the researchers pursuing the goal of increasing that number to 350 by mid-2024. With each person carrying a paired set of chromosomes, the current reference actually includes 94 distinct genome sequences, with a goal of reaching 700 distinct genome sequences by the completion of the project.
Read the full press release on the NHGRI website.